Pacira BioSciences develops, manufactures, markets, and sells non-opioid pain management solutions. Products include EXPAREL, ZILRETTA, and iovera system. The company has a development agreement with Aratana Therapeutics for NOCITA. Pacira was previously known as Pacira Pharmaceuticals before changing its name in 2019.
| Indicator | Value |
|---|---|
| PER | 149.0 |
| EV/EBITDA | 10.0 |
| Price/Free Cash Flow' | 7.7 |
| ROIC | 12.8% |
| Net Debt/EBITDA | 2.4 |